$PCRX

$36.38 -$0.04 (0.11%) Close

$PCRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 39.9M shares outstanding

Who owns PCRX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 60.5%

BlackRock, Inc. 16.8% · Doma Perpetual Capital Management LLC 7.0%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

253

+11 vs last qtr

Net shares bought

+130.1K

by institutions in Q2 2026

New / sold out

38 / 27

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

UBS Group AG +358.2K
Two Sigma Investments, LP +197.8K

Biggest sellers in Q2 2026

Citadel Advisors LLC −635.1K
First Trust Advisors LP −290.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.96M

18 notices from 6 people

Shares covered

122.8K

0.31% of the company

Arranged in advance

93%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Cross Shawn Officer 10b5-1 $1.52M
Williams Kristen Officer 10b5-1 $498K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+21.0%

+2.14% a year

Each share's claim on the business

−17.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$173M vs $415M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years67% 3–5 years12% 1–3 years16% Under 1 year6%

Quarterly turnover

7.2%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting PCRX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	6.7M	16.82%	−29.5K (−0.4%)	≤2021	0.0%
Shares held by quarter Peak holding7.8M (Q2'25) Change over 8 quarters−1.1M Share of the company16.820% BlackRock, Inc.'s full portfolio →
DP Doma Perpetual Capital Management LLC 13D · 0.0%	2.8M	6.97%	Unchanged	2023	16.4%
Shares held by quarter Peak holding2.8M (Q4'25) Change over 8 quarters+1.0M Share of the company6.970% Disclosed stake13D · 0.0% Doma Perpetual Capital Management LLC's full portfolio →

BlackRock, Inc.

6.7M

% of company

16.82%

Change vs last qtr

−29.5K (−0.4%)

Held since

≤2021

Doma Perpetual Capital Management LLC

13D · 0.0%

2.8M

% of company

6.97%

Change vs last qtr

Unchanged

Held since

2023

28 more super investors behind a free account

See every manager holding Pacira BioSciences, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PCRX on Form N-PORT; together they hold 48.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$60.2M	2.4M	5.95%	0.05%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$30.4M	1.2M	3.01%	0.00%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$60.2M

% of company

5.95%

% of the fund

0.05%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$30.4M

% of company

3.01%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Pacira BioSciences, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LF Lee Frank D. Insider	660.8K	1.66%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.660% Lee Frank D.'s insider activity →
SJ Slonin Jonathan Insider	216.4K	0.54%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.540% Slonin Jonathan's insider activity →

Lee Frank D.

Insider

660.8K

% of company

1.66%

Change vs last qtr

—

Held since

—

Slonin Jonathan

Insider

216.4K

% of company

0.54%

Change vs last qtr

—

Held since

—

14 more holders behind a free account

See every insider and 5%+ holder of Pacira BioSciences, Inc..

Comments